# Willamette Valley Vineyards Inc: overview WVVI · Nasdaq · CIK 838875 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/wvvi.md) · [Financials](/companies/wvvi/financials.md) · [Filings](/companies/wvvi/filings.md) · [Insiders](/companies/wvvi/insiders.md) Latest reported revenue: [$10.0m](/filings/0001199835-26-000283.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:Revenues, accession 0001199835-26-000283). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [9.4](/filings/0001199835-25-000384.md) | [11.3 d](/filings/0001199835-26-000061.md) | [7.5](/filings/0001199835-26-000146.md) | [10.2](/filings/0001199835-26-000283.md) | [8.4](/filings/0001199835-25-000384.md) | [11.1 d](/filings/0001199835-26-000061.md) | [8.3](/filings/0001199835-26-000146.md) | [10.0](/filings/0001199835-26-000283.md) | | Gross margin | % | [62.0%](/filings/0001199835-25-000384.md) | [58.9% d](/filings/0001199835-26-000061.md) | [63.1%](/filings/0001199835-26-000146.md) | [61.0%](/filings/0001199835-26-000283.md) | [59.9%](/filings/0001199835-25-000384.md) | [58.6% d](/filings/0001199835-26-000061.md) | [60.9%](/filings/0001199835-26-000146.md) | [57.5%](/filings/0001199835-26-000283.md) | | Operating margin | % | [(1.5%)](/filings/0001199835-25-000384.md) | [6.9% d](/filings/0001199835-26-000061.md) | [(11.5%)](/filings/0001199835-26-000146.md) | [3.9%](/filings/0001199835-26-000283.md) | [(14.5%)](/filings/0001199835-25-000384.md) | [2.2% d](/filings/0001199835-26-000061.md) | [(8.2%)](/filings/0001199835-26-000146.md) | [(13.5%)](/filings/0001199835-26-000283.md) | | Net margin | % | [(3.0%)](/filings/0001199835-25-000384.md) | [4.4% d](/filings/0001199835-26-000061.md) | [(9.7%)](/filings/0001199835-26-000283.md) | [0.9%](/filings/0001199835-26-000283.md) | [(13.1%)](/filings/0001199835-25-000384.md) | [7.3% d](/filings/0001199835-26-000061.md) | [(6.8%)](/filings/0001199835-26-000283.md) | [(13.8%)](/filings/0001199835-26-000283.md) | | Diluted EPS | $ per share | not reported | not reported | [(0.26)](/filings/0001199835-26-000146.md) | [(0.09)](/filings/0001199835-26-000283.md) | not reported | not reported | [(0.24)](/filings/0001199835-26-000146.md) | [(0.40)](/filings/0001199835-26-000283.md) | | Free cash flow | $m | [(0.4) d](/filings/0001199835-25-000384.md) | [(1.4) d](/filings/0001199835-26-000061.md) | [(1.4)](/filings/0001199835-26-000146.md) | [1.2 d](/filings/0001199835-26-000283.md) | [(1.5) d](/filings/0001199835-25-000384.md) | [(0.5) d](/filings/0001199835-26-000061.md) | [0.7](/filings/0001199835-26-000146.md) | [1.9 d](/filings/0001199835-26-000283.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [31.8](/filings/0001199835-23-000177.md) | [33.9](/filings/0001199835-24-000132.md) | [39.1](/filings/0001199835-25-000089.md) | [39.8](/filings/0001199835-26-000061.md) | [37.2](/filings/0001199835-26-000061.md) | | Gross margin | % | [58.7%](/filings/0001199835-23-000177.md) | [55.4%](/filings/0001199835-24-000132.md) | [57.6%](/filings/0001199835-25-000089.md) | [60.8%](/filings/0001199835-26-000061.md) | [60.5%](/filings/0001199835-26-000061.md) | | Operating margin | % | [11.6%](/filings/0001199835-23-000177.md) | [(1.6%)](/filings/0001199835-24-000132.md) | [(3.1%)](/filings/0001199835-25-000089.md) | [1.4%](/filings/0001199835-26-000061.md) | [(3.9%)](/filings/0001199835-26-000061.md) | | Net margin | % | [7.7%](/filings/0001199835-23-000177.md) | [(1.9%)](/filings/0001199835-24-000132.md) | [(3.1%)](/filings/0001199835-25-000089.md) | [(0.3%)](/filings/0001199835-26-000061.md) | [(2.5%)](/filings/0001199835-26-000061.md) | | Diluted EPS | $ per share | [0.20](/filings/0001199835-22-000167.md) | not reported | not reported | not reported | not reported | | Free cash flow | $m | [(7.5)](/filings/0001199835-23-000177.md) | [(17.5)](/filings/0001199835-24-000132.md) | [(6.3)](/filings/0001199835-25-000089.md) | [(5.1)](/filings/0001199835-26-000061.md) | [(2.2)](/filings/0001199835-26-000061.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/wvvi/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $499.2k | 198,896 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $159.0k | 63,352 | | Reduced −2,700 | | [Next Capital Management LLC](/funds/1752762.md) | 2026-06-30 | $137.5k | 54,800 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $89.9k | 35,798 | | Reduced −911 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $70.0k | 27,905 | | Reduced −498 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $64.9k | 25,866 | | Reduced −50 | | [Teton Advisors, LLC](/funds/2086025.md) | 2026-06-30 | $51.5k | 20,500 | | Unchanged | | [GABELLI FUNDS LLC](/funds/1081407.md) | 2026-06-30 | $50.2k | 20,000 | | Unchanged | | [EP Wealth Advisors, LLC](/funds/1540569.md) | 2026-06-30 | $40.6k | 16,168 | | Added +376 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $36.2k | 14,417 | | New +14,417 | ## Recent filings [All 419 filings](/companies/wvvi/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-12 | 20:16 ET | [10-Q](/filings/0001199835-26-000283.md) | Quarterly report, period 2026-06-30 | 0001199835-26-000283 | | 2026-07-14 | 20:07 ET | [8-K](/filings/0001199835-26-000257.md) | 5.02 Departure or appointment of officers or directors | 0001199835-26-000257 | | 2026-07-14 | 20:05 ET | [8-K](/filings/0001199835-26-000256.md) | 5.07 Shareholder vote results | 0001199835-26-000256 | | 2026-05-28 | 20:04 ET | [DEF 14A](/filings/0001199835-26-000205.md) | Proxy statement, period 2026-07-11 | 0001199835-26-000205 | | 2026-05-20 | 20:10 ET | [8-K](/filings/0001199835-26-000182.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001199835-26-000182 | | 2026-05-13 | 20:30 ET | [10-Q](/filings/0001199835-26-000146.md) | Quarterly report, period 2026-03-31 | 0001199835-26-000146 | | 2026-03-24 | 20:30 ET | [10-K](/filings/0001199835-26-000061.md) | Annual report, period 2025-12-31 | 0001199835-26-000061 | | 2026-02-17 | 21:04 ET | [8-K](/filings/0001199835-26-000047.md) | 5.02 Departure or appointment of officers or directors | 0001199835-26-000047 | | 2025-11-13 | 22:20 ET | [10-Q](/filings/0001199835-25-000384.md) | Quarterly report, period 2025-09-30 | 0001199835-25-000384 | | 2025-08-12 | 20:16 ET | [10-Q](/filings/0001199835-25-000246.md) | Quarterly report, period 2025-06-30 | 0001199835-25-000246 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001199835-26-000061.md), filed Mar 24, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7975e1e7-898a-46d8-833f-6ffb9024e3df) ## About the filer - CIK: 838875 - Tickers: WVVI, WVVIP - Exchange: Nasdaq - SIC code: 2080 Beverages - State of incorporation: OR - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.